Study of the natural course of noncirrhotic portal hypertension
Part of Digestive system, Genetic & congenital, Heart & circulation, Hormones & metabolism, Immune system & allergy, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study follows people with noncirrhotic portal hypertension (NCPH) or people at risk for it to better understand how the condition progresses over time. It does not sound like a medication trial—more like careful monitoring to learn what happens in different people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older (or 12–17 years old if a minor can join)
- You have a known diagnosis of noncirrhotic portal hypertension, or a condition that can put you at risk
- If you can become pregnant, you agree to use effective birth control (unless you’re menopausal or you’ve had a hysterectomy)
- You are not currently pregnant
- You do not have evidence of other liver diseases that usually lead to cirrhosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests a noninvasive ultrasound-based method to estimate portal hypertension, which is high blood pressure in the liver’s blood vessels. It aims to help doctors measure how severe the liver circulation problem is without needing invasive pressure testing.
This trial is for people with liver problems and high blood pressure in the veins of the liver (called portal hypertension). It will look at how the condition affects patients with and without cirrhosis (scarring of the liver).
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This study tests a new way to measure if a type of blood pressure medicine called non-selective beta-blockers (NSBBs) is helping patients with cirrhosis. It uses a thin, flexible tube with a camera (endoscope) to measure pressures in the liver and a nearby vein. If you have cirrhosis with high pressure in the portal vein but haven't started NSBBs yet, this study may help your doctor decide if the medicine is working for you.
This study looks at people who have both liver blood vessel issues and high blood pressure in the lungs. It aims to learn more about this condition and how it affects people over time, which may help improve future care.
This study follows people with advanced chronic liver disease to understand how their condition changes over time. If you have cirrhosis or high liver stiffness, you may be able to join to help researchers track the disease and learn more about it.
Hear when a new Cystic Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.